Navigation Links
Medivation in Medical News

Medivation Announces Second Quarter 2009 Financial Results Teleconference and Webcast on August 5, 2009

...n the Company's website for 30 days. About medivation Medivation, Inc. is a biopharmaceutical co...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...

Medivation to Present at 8th Annual Needham Life Sciences Conference

...e Hotel. Dr. Hung will provide an overview of medivation and its clinical development programs for Dimebon ... days following the live presentation. About medivation Medivation, Inc. is a biopharmaceutical com...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...

Medivation Announces Offering of 2,750,000 Shares of Common Stock

...ment (telephone number 718-242-8002). About medivation Medivation, Inc. is a biopharmaceutical compan...s release contains "forward-looking statements" of medivation within the meaning of the federal securities laws....ts that speak only as of the date of this release. medivation undertakes no obligation to update publicly any fo...

Medivation Announces Upcoming Presentation of New MDV3100 Data in Patients With Advanced Prostate Cancer at 45th American Society of Clinical Oncology Annual Meeting

...rease global access to cutting-edge science. medivation recently received written permission from the U.S....reatment options and a poor prognosis. About medivation Medivation, Inc. is a biopharmaceutical company...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...

Medivation to Present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference

...ew York. Dr. Hung will provide an overview of medivation and its clinical development programs at 10:30 a.m... days following the live presentation. About medivation Medivation, Inc. is a biopharmaceutical compan...es for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...

Medivation Reports First Quarter 2009 Financial Results and Provides Corporate Update

...st quarter of 2009, the true-up payment payable to medivation was $5.8 million. medivation presents these cost-sharing true-up payments in th...expense line of its statement of operations. medivation reported a net loss for the quarter ended March 31...

New Prostate Cancer Drug May Hold Promise

... he said. Based on those results, Scher said, an application for a large-scale trial has been submitted to the U.S. Food and Drug Administration by medivation Inc., a California-based biopharmaceutical company that has licensed the drug, now called MDV3100. The hope is that the trial will lead to FDA approva...

Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer

...he androgen receptor and DNA binding. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...

Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009

...on the Company's website for 30 days. About medivation Medivation, Inc. is a biopharmaceutical company...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...

Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients

...o the event listing in the Investor section of the medivation website. A replay of the webcast will be availabl...on the Company's website for 30 days. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...
Medivation in Medical Technology

Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease

--New 12-month study broadens Phase 3 clinical program to further evaluate the benefits of Dimebon in Alzheimer's Disease-- NEW YORK and SAN FRANCISCO, April 15 /PRNewswire-FirstCall/ -- Pfizer (NYSE: PFE ) and Medivation, Inc. (Nasdaq: MDVN ) today announced the initiation of a 12-mont...

Medivation Announces Positive New Efficacy Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients

...ated at doses up to and including 240 mg/day. medivation plans to initiate a pivotal Phase 3 clinical trial...he androgen receptor and DNA binding. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...

Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients

...e androgen receptor and DNA binding. About medivation Medivation, Inc. is a biopharmaceutical co...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation entered into a global agreement with Pfizer Inc to...

Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimer's Disease

...of Action In a podium presentation at ICAD 2008, medivation presented new data on Dimebon's novel mitochondria...ochondrial mechanism of action. On July 7, 2008, medivation announced positive safety and efficacy results fro...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...

Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimer's Disease

...rates through a novel mitochondrial mechanism of action. On July 7, 2008, medivation announced positive safety and efficacy results from its Phase 2 trial of Di...gs to treat serious diseases for which there are limited treatment options. medivation aims to transform the treatment of these diseases and offer hope to critica...

Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease

...novel mitochondrial mechanism of action. Teleconference/Webcast Details medivation will host a teleconference at 5:00 p.m. Eastern Daylight Time today. To par...gs to treat serious diseases for which there are limited treatment options. medivation aims to improve the treatment of these diseases and offer hope to criticall...

Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease

...pment of novel small molecule drugs to treat serious diseases of the central nervous system and cancers for which there are limited treatment options. medivation aims to revolutionize the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical d...

Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimer's Disease

...-6386). Results of First Pivotal Phase 3 Trial medivation previously announced results from its first pivota...rough a novel mitochondrial mechanism of action. medivation is also evaluating Dimebon in an ongoing Phase 2 c...ers for which there are limited treatment options. medivation aims to revolutionize the treatment of these disea...

Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting

...e patients and are also exploring higher doses." medivation expects to complete the study, and report final to...e results, in 2008. If these results are positive, medivation expects to seek U.S. Food and Drug Administration ...ers for which there are limited treatment options. medivation aims to revolutionize the treatment of these disea...

Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting

...ity, pharmacokinetics, effects on serum PSA levels and disease progression. medivation expects to complete the study and report final top-line results in 2008. ...l nervous system and cancers for which there are limited treatment options. medivation aims to revolutionize the treatment of these diseases and offer hope to cri...
Medivation in Biological News

New drug shows promise in treating drug-resistant prostate cancer

...pounds were licensed by the pharmaceutical company medivation Inc., which chose to test MDV3100 in clinical tria...e Food and Drug Administration has agreed to allow medivation to begin what Jung described as "the pivotal Phase...eptors. The promising laboratory studies led medivation to license the drugs for commercial development. ...

New medications show promise in treating drug-resistant prostate cancer

...cancer cells. The new compounds manufactured by the pharmaceutical company medivation and known as MDV3100 and RD162 appear to work well even in prostate cells ...eptor is present, Sawyers explained. The promising laboratory studies led medivation to license the drugs for commercial development, said Sawyers, who serves a...
Medivation in Biological Technology

Medivation Completes Enrollment in Confirmatory, Pivotal Phase 3 'CONNECTION' Trial of Dimebon in Patients With Alzheimer's Disease

...ngton disease, a Phase 2 study has been completed. medivation and Pfizer expect to initiate a Phase 3 trial this... well as delusions or hallucinations. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...

Medivation Announces Pricing of Public Offering

...ment (telephone number 718-242-8002). About medivation Medivation, Inc. is a biopharmaceutical com...s release contains "forward-looking statements" of medivation within the meaning of the federal securities laws....ts that speak only as of the date of this release. medivation undertakes no obligation to update publicly any fo...

Medivation Announces First Quarter 2009 Financial Results Teleconference and Webcast on May 11, 2009

...on the Company's website for 30 days. About medivation Medivation, Inc. is a biopharmaceutical compan...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...

Medivation Announces Upcoming Scientific Presentations at Medical Conferences

...om currently available AD medications. About medivation Medivation, Inc. is a biopharmaceutical compan...es for which there are limited treatment options. medivation aims to transform the treatment of these diseases ...patients and their caregivers. In September 2008, medivation announced a global agreement with Pfizer Inc to de...

Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update

...th quarter of 2008, the true-up payment payable to medivation was $3.5 million. medivation presents these cost-sharing true-up payments in th... expense line of its statement of operations. medivation reported a net loss for the quarter ended December...

Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients

...CO's 2009 Genitourinary Cancers Symposium - - medivation to Host Conference Call and Webcast Presentation w...state cancer, I am enthusiastic about working with medivation to advance MDV3100 into Phase 3 clinical developme...o the event listing in the Investor section of the medivation website. A replay of the webcast will be availabl...

Medivation Presents New Data on Dimebon's Novel Mechanism of Action

... is planned in Huntington's disease. About medivation Medivation, Inc. is a biopharmaceutical co...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation entered into a global agreement with Pfizer Inc to...

Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference

...ays following the live presentation. About medivation Medivation, Inc. is a biopharmaceutical co...ses for which there are limited treatment options. medivation aims to transform the treatment of these diseases ... patients and their caregivers. In September 2008, medivation entered into a global agreement with Pfizer Inc to...

Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update

...s diseases. Under the terms of the agreement, medivation has received an up-front cash payment of $225 ...um tolerated dose (MTD) has not been reached. -- medivation expects to seek FDA agreement to begin a pivotal P... 2009. Third Quarter 2008 Financial Results medivation reported a net loss for the quarter ended Septembe...

Medivation Announces Third Quarter 2008 Teleconference and Webcast on November 10, 2008

...utical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical devel...
Other Tags
(Date:7/12/2014)... ON Canada (PRWEB) July 12, 2014 Sean Francis, ... for throwing out special challenges to his clients. He’s also known ... Club. He recently found a way to combine the two and ... has raised $2,000 for the Boys and Girls Club. , The ... Program, which started on June 23rd. Francis sent out emails and ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 As DePuy ... forward in U.S. courts, Bernstein Liebhard LLP notes the ... ion levels to the failure of metal-on-metal hip replacements. ... of The Journal of Bone & Joint Surgery, looked ... Articular Surface Replacement prostheses at least twelve months earlier. ...
(Date:7/12/2014)... Columbus, OH (PRWEB) July 12, 2014 Wright ... lawsuit against DePuy Orthopedics , Inc., a subsidiary of Johnson ... that he suffers chronic pain after receiving a metal-on-metal DePuy ... years later to remove the artificial hip implant. The DePuy ... District Court, Northern District of Texas (Case No. 3:14-cv-2427) where ...
(Date:7/12/2014)... York, NY (PRWEB) July 12, 2014 As ... (the National Institute of Standards and Technology), the June 25th, ... the electronic discovery world. It was also ... finally in, depending on whether it was seen from an ... But this much is fact, there is now precedent which ...
(Date:7/12/2014)... recent article released by Seattle's well known plastic surgeon, Dr. ... cosmetic surgical procedures in summer months . , ... to enliven the rainy Pacific Northwest, many people are turning ... work out as much during the winter as they had ... people eager to look their best for their summer vacations, ...
Breaking Medicine News(10 mins):Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 2Health News:Kawartha Lakes Fit Body Boot Camp’s Successful Fat Loss Challenge Results in $2,000 to Boys and Girls Club 3Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 3Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 5Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 2Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 3Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 4Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 5Health News:Best Summer Cosmetic Surgeries Revealed in Article By Seattle Plastic Surgeon 2
(Date:7/11/2014)... BostonThe American Society for Bone and Mineral Research awarded ... of Medicine (BUSM), with the 2014 Louis V. Avioli ... at BUSM, is internationally known for revolutionizing the understanding ... , The award honors a member of the ... fundamental contributions to bone and mineral basic research. It ...
(Date:7/11/2014)... of researchers from The Chinese University of Hong Kong, ... wild soybean linked to salt tolerance, with implication for ... This study published online in Nature Communications ... for crop improvement. , Soybean is an important crop ... cultivated soybeans have less genetic diversities than their wild ...
(Date:7/11/2014)... 11, 2014 Researchers have pioneered a revolutionary ... new technology, called Virtual Finger, allows scientists to ... neurons and synapses using the flat surface of ... 3D imaging studies orders of magnitude more efficient, ... level across many areas of experimental biology. The ...
Breaking Biology News(10 mins):BUSM's Michael F. Holick receives American Society for Bone and Mineral Research award 2BGI reports a novel gene for salt tolerance found in wild soybean 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
Other Contents